Life Sciences

OncoImmunity is a bioinformatics company offering proprietary machine-learning based software to address the key knowledge gaps in the prediction of bone fide immunogenic neoantigens for personalized cancer immunotherapy. OncoImmunity is dedicated to develop software solutions that facilitate effective patient selection for cancer immunotherapy, and identify optimal neoantigen targets for truly personalised cancer vaccines & cell therapies in a clinically actionable time-frame. Headquartered at the Oslo Cancer Cluster [...]

SpinChip Diagnostics is developing a game changing and proprietary platform for in vitro diagnostics point of care analyses. The platform will make it possible to perform a broader range of analyses using one platform and to transfer analyses from central laboratories to point of care without loss in quality. All analyses are performed within a few minutes based on a fraction of a droplet of blood [...]

DoMore Diagnositics is a newly established company in Oslo on a mission to transform cancer diagnostics with artificial intelligence. The technology is based on prominent international research from leading universities. For five years, researchers at Oslo University Hospital, University of Oslo, University of Oxford and University College London have used deep learning and vast reserves of patient data to develop algorithms that provide the patients with a more [...]